Die EMA-Leute sind auch in Indien um die Anlagen des Serum-Instituts, Kooperationspartner von Astrazeneca für die Produktion von AZD1222, zu inspizieren. Vermutlich um festzustellen, ob sie als Zulieferer für die EU in Frage kommen:
https://www.reuters.com/articl…u-exclusive-idUSKCN2AT1J0
ZitatAlles anzeigenEurope’s drug regulator is auditing the manufacturing site of the Serum Institute of India (SII), a source with knowledge of the matter said, [...]
[...]
The precise reason for the audit of SII’s manufacturing processes and facilities was not clear, but a green light would mean the drug could be exported to the European Union, the source said, declining to be identified because the review is confidential.
[...]
The European Medicines Agency (EMA) and European Commission, which has overseen the bloc’s supply contract with AstraZeneca, declined to comment specifically on the audit.
But spokespeople for both organisations confirmed in emails the EMA would need to approve the site and change marketing authorisation for the shot to be exported to the bloc.
UK hat sich da auch schon vor einer Weile rumgedrückt. Ist fast wieder wie in Kolonialzeiten.
Wobei die Inder natürlich auch ihren enormen Eigenbedarf haben:
https://twitter.com/adarpoonaw…tatus/1363346341275967488